Rep. Israel Mulls FDA Authority, Funding As Counterfeits Come To Forefront
This article was originally published in The Tan Sheet
Executive Summary
A bill introduced by Rep. Steve Israel (D-NY) would provide for an additional $300 mil. in funding to FDA over the next five years for inspections and investigations by the agency of incidents of drug counterfeiting
You may also be interested in...
FDA Counterfeiting Task Force To Study Tougher Criminal Action As Deterrent
An FDA task force could look to Florida's new drug wholesaler licensing requirements as a model that all states should adopt to combat drug counterfeiting
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands